標題: Titlebook: Glioma Imaging; Physiologic, Metabol Whitney B. Pope Book 2020 Springer Nature Switzerland AG 2020 glioma.brain tumor.neuroimaging.low grad [打印本頁] 作者: 母牛膽小鬼 時間: 2025-3-21 16:40
書目名稱Glioma Imaging影響因子(影響力)
書目名稱Glioma Imaging影響因子(影響力)學(xué)科排名
書目名稱Glioma Imaging網(wǎng)絡(luò)公開度
書目名稱Glioma Imaging網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Glioma Imaging被引頻次
書目名稱Glioma Imaging被引頻次學(xué)科排名
書目名稱Glioma Imaging年度引用
書目名稱Glioma Imaging年度引用學(xué)科排名
書目名稱Glioma Imaging讀者反饋
書目名稱Glioma Imaging讀者反饋學(xué)科排名
作者: strdulate 時間: 2025-3-21 23:06
Surrogates for Disease Status: Contrast Enhancement Including Limitations of Pseudoprogression and re is overwhelming evidence that noninvasive methods are insufficient, mainly due to the infiltrative nature and heterogeneity of glioma and, most importantly, of these tumors under/after therapy. The heterogeneity of gliomas is enhanced by any treatment, since sensitivity to tumor therapy might dif作者: 擁護 時間: 2025-3-22 03:51
The Relationship Between Biological and Imaging Characteristics in Enhancing and Nonenhancing Gliomoma seen on routine MR imaging. Here we focus on physiologic and metabolic MR imaging techniques including diffusion, perfusion, and spectroscopy, as they relate to histopathology and molecular features of gliomas. The utility of these advanced techniques in evaluating glioma treatment response is a作者: 放縱 時間: 2025-3-22 04:53 作者: 嚴峻考驗 時間: 2025-3-22 11:07
,Advanced Physiologic Imaging: Perfusion?– Theory and Applications,hich is a hallmark of cancer cells, is crucial for the translation of new therapies into the clinic and for assessing therapeutic effects in individual patients. In this context, noninvasive characterization of hemodynamic parameters on MRI has emerged as an important diagnostic tool. This chapter a作者: Sciatica 時間: 2025-3-22 15:36 作者: Sciatica 時間: 2025-3-22 17:38 作者: 獎牌 時間: 2025-3-22 22:42 作者: reperfusion 時間: 2025-3-23 05:14 作者: Pedagogy 時間: 2025-3-23 08:58 作者: 輕浮女 時間: 2025-3-23 11:51 作者: 到婚嫁年齡 時間: 2025-3-23 14:20
C-13 Hyperpolarized MR Spectroscopy for Metabolic Imaging of Brain Tumors, incorporated into clinical patient management in order to make personalized neuro-oncology a reality. One promising approach is metabolic imaging, which can translate metabolic information that reflects the molecular features of glioma into noninvasive imaging biomarkers that can impact diagnosis, 作者: 做方舟 時間: 2025-3-23 22:03 作者: 宿醉 時間: 2025-3-24 00:40 作者: 污穢 時間: 2025-3-24 05:25 作者: 顧客 時間: 2025-3-24 08:45 作者: 淡紫色花 時間: 2025-3-24 12:49 作者: NAG 時間: 2025-3-24 18:50
Richard P. Pharis,David M. Reidreatment monitoring for tumor recurrence. In this chapter, standard therapy for high- and low-grade gliomas is outlined with emphasis on how imaging contributes to various stages of treatment. Limitations of conventional imaging techniques for these roles are also discussed to highlight the need of 作者: 激怒 時間: 2025-3-24 21:55 作者: Urea508 時間: 2025-3-24 23:37
Hormonal Regulation of Mammary Tumorsoma seen on routine MR imaging. Here we focus on physiologic and metabolic MR imaging techniques including diffusion, perfusion, and spectroscopy, as they relate to histopathology and molecular features of gliomas. The utility of these advanced techniques in evaluating glioma treatment response is a作者: 前兆 時間: 2025-3-25 03:51
Claude Penel,Thomas Gaspar,Hubert Greppinntrast-enhancing tumor burden can be challenging in the presence of T1 shortening from postsurgical blood products or treatments or use of therapies that alter vascular permeability. Contrast-enhanced T1-weighted digital subtraction is a quick and simple technique for increasing lesion conspicuity e作者: Keratin 時間: 2025-3-25 11:12 作者: 承認 時間: 2025-3-25 14:28 作者: municipality 時間: 2025-3-25 17:42 作者: 詞匯表 時間: 2025-3-25 20:29
Thomas Rabe,B. Runnebaum,H. Weickerlioma, incorporating these features into the definitions of a variety of brain tumors for the first time. Several of these genetic alterations, such as IDH mutation and 1p/19q codeletion, can be assessed at imaging, with approaches including visual inspection, advanced MR and PET techniques, and mac作者: POLYP 時間: 2025-3-26 00:45
Is VIP a Neuroregulator or a Hormone?,gement. We first review molecular markers acknowledged under the recent World Health Organization (WHO) diagnostic criteria that have enabled prognostic stratification of gliomas into distinct molecular subtypes. A discussion of current imaging markers follows, including surrogate markers of histolo作者: 蕁麻 時間: 2025-3-26 06:40 作者: obstruct 時間: 2025-3-26 10:08
Shubham Mule,Mayank Handa,Rahul Shuklasequent evolution and clinical phenotype of this class of brain tumors. Mutations in the residues R132 of IDH1 or R172 of IDH2 switch the enzymatic activity towards the production of D-2-hydroxyglutarate (D-2HG) at high intracellular concentration. IDH1 and IDH2 are important hubs in the metabolic n作者: angiography 時間: 2025-3-26 13:51
https://doi.org/10.1007/978-1-4614-6268-2 incorporated into clinical patient management in order to make personalized neuro-oncology a reality. One promising approach is metabolic imaging, which can translate metabolic information that reflects the molecular features of glioma into noninvasive imaging biomarkers that can impact diagnosis, 作者: 暫時中止 時間: 2025-3-26 20:10
Yoichi Arai M.D., Ph.D.,Koji Mitsuzuka provide clinically relevant information beyond structural magnetic resonance imaging (MRI). In contrast to the widely used PET tracer 2-[.F]fluoro-2-deoxy-D-glucose (FDG), the uptake of radiolabeled amino acids such as .-(2-[.F]fluoroethyl)-L-tyrosine (FET) or 3,4-dihydroxy-6-[.F]-fluoro-L-phenylal作者: 吃掉 時間: 2025-3-26 22:46 作者: motivate 時間: 2025-3-27 04:36
,Exogene Einflüsse und Ovarialfunktion,genomics) that have clinical utility. While attempts have been made to visually decode various imaging features on MRIs of gliomas, an artificial intelligence approach is better suited to tease out pixel-level subtleties that may reflect different mutations. Machine learning, a form of artificial in作者: Outspoken 時間: 2025-3-27 07:59 作者: ALB 時間: 2025-3-27 09:48
Bildung, Freisetzung und Wirkung MR scanner systems and pulse sequence parameters for the same relative MR contrast (e.g., T1- or T2-“weighting”) can result in dramatic differences in perceived image contrast, leading to difficulty in interpretation of imaging results in multicenter clinical trials. Therefore, consensus recommenda作者: 有權(quán)威 時間: 2025-3-27 14:30 作者: 外形 時間: 2025-3-27 18:24
https://doi.org/10.1007/978-3-030-27359-0glioma; brain tumor; neuroimaging; low grade glioma; radiogenomics; metabolic imaging作者: Minatory 時間: 2025-3-27 23:22
Hormonal Regulation of Mammary Tumorsoma seen on routine MR imaging. Here we focus on physiologic and metabolic MR imaging techniques including diffusion, perfusion, and spectroscopy, as they relate to histopathology and molecular features of gliomas. The utility of these advanced techniques in evaluating glioma treatment response is also discussed.作者: Neutropenia 時間: 2025-3-28 03:20 作者: 抒情短詩 時間: 2025-3-28 08:29 作者: 植物茂盛 時間: 2025-3-28 12:24 作者: climax 時間: 2025-3-28 15:56
Thomas Rabe,B. Runnebaum,H. Weickerost-treatment imaging. In the future, the importance of genetic features in glioma diagnosis and treatment will only increase, and it is incumbent upon neuroradiologists to stay abreast of these developments in order to provide optimal patient care.作者: endoscopy 時間: 2025-3-28 22:15
https://doi.org/10.1007/978-1-4614-6268-2state of the art in glioma imaging using hyperpolarized .C-MRS. We will review the various hyperpolarized .C-MRS studies in preclinical glioma models as well as studies in brain tumor patients that highlight the promise and the challenges associated with translation of this technology to the clinic.作者: Rheumatologist 時間: 2025-3-29 02:57
,Exogene Einflüsse und Ovarialfunktion, MR images of gliomas by IDH1, 1p19q codeletion, and MGMT promoter methylation status. As these frameworks continue to improve, radiomics and imaging genomics could potentially serve a role in prognosticating outcomes and directing treatments for patients with gliomas.作者: SPURN 時間: 2025-3-29 05:12
Parametric Response Map (PRM) Analysis Improves Response Assessment in Gliomas,i-parametric imaging biomarker derived from MR perfusion and diffusion-weighted imaging (DWI) using a PRM analysis method provides early identification of high-grade glioma chemoradiation resistance. Further validation of PRM-derived imaging biomarkers is required prior to routine clinical application as an early treatment response marker.作者: capillaries 時間: 2025-3-29 10:55
Review of WHO 2016 Changes to Classification of Gliomas; Incorporation of Molecular Markers,ost-treatment imaging. In the future, the importance of genetic features in glioma diagnosis and treatment will only increase, and it is incumbent upon neuroradiologists to stay abreast of these developments in order to provide optimal patient care.作者: 夜晚 時間: 2025-3-29 11:52 作者: 控制 時間: 2025-3-29 16:10 作者: 過去分詞 時間: 2025-3-29 20:48 作者: CHART 時間: 2025-3-30 00:47 作者: orthodox 時間: 2025-3-30 06:22
Peter B. Kaufman,Il Song,Richard P. Pharisl patients. In this context, noninvasive characterization of hemodynamic parameters on MRI has emerged as an important diagnostic tool. This chapter aims to provide a comprehensive overview of the basic principles and clinical applications of the various MRI perfusion techniques in neuro-oncology.作者: prostate-gland 時間: 2025-3-30 11:36
Is VIP a Neuroregulator or a Hormone?,ic stratification of gliomas into distinct molecular subtypes. A discussion of current imaging markers follows, including surrogate markers of histological tumour grade and molecular features, and characteristics that aid in early detection of malignant transformation (MT).作者: 冥想后 時間: 2025-3-30 14:14
